Ziptek LLC, founded by Sarasota-based orthopedic surgeon Dr. William Bennett M.D., is proud to announce its newly obtained FDA-approval for the ZipE® knotless tissue repair and attachment device. ZipE® is an absorbable button that moves down a suture, locking itself from moving backward with each forward movement. It can be used in minimally-invasive techniques and open surgeries to accomplish tissue-to-tissue and tissue-to-bone repair. Most importantly, since it functions similar to a zip tie, ZipE® prevents the need to tie knots in small spaces and creates a superior contact of the repaired tissue compared to any other device on the market.
Ziptek LLC exhibited at the March 2017 AAOS Meeting in San Diego and garnered significant national and international interest by surgeons and distributors alike for the newly FDA-approved ZipE®. Given that the U.S soft tissue repair market generates $2 to $3 billion per year, with at least 500,000 rotator cuff and 1,000,000 ankle ligament cases annually, the ZipE® can play a major role in transforming the surgical outcomes of countless patients. It offers the unprecedented ability to disperse pressure across a larger surface area and help prevent the suture from tearing out through the tissue. This makes ZipE® incredibly valuable for better and improved tissue healing with a far lower rate of non-healing and re-tears.
Dr. William F. Bennett M.D., an orthopedic surgeon with more than 26 years of experience, imagined the first knotless tissue repair solution and applied for its patent in 1995. By 2003, he had a total of three patents and made the decision to commercialize in 2009 with additional patents. Dr. Bennett officially founded Ziptek LLC in 2012 and was then joined by an investor in 2014. His company is decisively interacting with various large national and international orthopedic training centers that continue real-time research to define the ZipE® device’s superiority for tissue repair.
Internal testing results indicate that the ZipE® device is a standout product in the tissue repair domain. According to these findings, the ZipE® can support better healing rates by providing the most resistance to rip through, the least gap formation, the most contact surface area, and homogeneous contact pressures. Since the ZipE® is absorbable, opposed to other devices on the market which are permanent and never absorb, it is better suited to allow tissue to fully regenerate. As the ZipE® degrades, it unloads stress and shields the tissue from the negative impacts of other devices.
Members of the community or media interested in learning more about the recent FDA approval of the ZipE® and its applications in orthopedic surgery are invited to use the following contact information:
NAME: Dr. William Bennett, M.D
ADDRESS: 1250 S. Tamiami Trail, Suite 303, Sarasota, FL 34239 US
PHONE: (941) 953-5509
EMAIL: [email protected]
Media ContactCompany Name: Ziptek LLCContact Person: Dr. William Bennett, M.DEmail: [email protected]Phone: (941) 953-5509Address:1250 S. Tamiami Trail, Suite 303 City: SarasotaState: FL 34239Country: United StatesWebsite: www.ziptekglobal.com